Senior insider sale
TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$339.8K
4.60K shares
What this filing means
LIN ELIZABETH YEU plans to sell 4.60K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $339.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/1/2026ACC: 0001959173-26-006596
Director
Since Dec 2021
4.60K
Shares to sell
$339.8K
Approx. market value
4.60K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Restricted Stock Vesting
Compensation
6/22/2024
2.60KRestricted Stock Vesting
Compensation
6/16/2023
2KTotal acquired4.60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/22/2024 | Restricted Stock Vesting Compensation | 2.60K | — |
6/16/2023 | Restricted Stock Vesting Compensation | 2K | — |
| Total | 4.60K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
4.60K
Market value
$339.8K
9/1/2026
Total
Units
4.60K
Value
$339.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/1/2026 | 4.60K | $339.8K | NASDAQ | Planned |
| Total | 4.60K | $339.8K | ||